تاريخ الإيرادات والأرباح والتدفقات النقدية من القوائم المالية الرسمية.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
الرسوم البيانية التفاعلية والقوائم الكاملة ← نموذج التقييم (DCF) ←
| قائمة الدخل | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| إجمالي الإيرادات | $13.6B | $13.2B | $12.7B | $12.3B | $12.6B | $12.4B | $10.1B | $10.0B | $13.2B | $12.5B | $11.6B | $10.6B | $10.4B | $9.6B | $8.9B | $8.5B | $7.5B | $6.5B | $6.4B | $5.9B | $5.2B |
| إجمالي الربح | $4.1B | $3.8B | $3.8B | $3.7B | $3.6B | $3.7B | $2.8B | $3.1B | $2.9B | $3.4B | $3.2B | $3.0B | $2.9B | $2.7B | $2.5B | $2.4B | $2.2B | $1.9B | $1.9B | $1.7B | $1.5B |
| هامش الربح الإجمالي % | 30.3% | 29.1% | 29.7% | 29.6% | 28.8% | 29.6% | 27.8% | 30.9% | 22.1% | 27.3% | 27.9% | 28.3% | 28.1% | 27.8% | 28.1% | 28.3% | 28.9% | 29.2% | 29.3% | 29.0% | 28.6% |
| الدخل التشغيلي (EBIT) | $774M | $758M | $729M | $714M | $938M | $855M | $567M | $733M | $693M | $865M | $817M | $769M | $715M | $677M | $634M | $582M | $536M | $462M | $443M | $386M | $304M |
| هامش التشغيل % | 5.7% | 5.8% | 5.8% | 5.8% | 7.4% | 6.9% | 5.6% | 7.3% | 5.2% | 6.9% | 7.1% | 7.2% | 6.9% | 7.1% | 7.1% | 6.8% | 7.1% | 7.1% | 6.9% | 6.5% | 5.9% |
| صافي الدخل | $403M | $398M | $390M | $416M | $538M | $624M | $402M | $508M | $536M | $406M | $507M | $479M | $466M | $444M | $388M | $368M | $326M | $309M | $247M | $235M | $183M |
| هامش الربح الصافي % | 3.0% | 3.0% | 3.1% | 3.4% | 4.2% | 5.0% | 4.0% | 5.1% | 4.1% | 3.3% | 4.4% | 4.5% | 4.5% | 4.6% | 4.3% | 4.3% | 4.3% | 4.7% | 3.9% | 4.0% | 3.5% |
| EBITDA | — | $1.0B | $941M | $877M | $977M | $1.1B | $727M | $916M | $756M | $1.1B | $958M | $906M | $886M | $820M | $760M | $716M | $637M | $558M | $508M | $481M | $387M |
| ربحية السهم (EPS) | $3.42 | $3.27 | $3.05 | $3.16 | $3.91 | $4.40 | $2.80 | $3.40 | $3.49 | $2.57 | $3.12 | $2.85 | $2.72 | $2.53 | $2.16 | $1.98 | $1.75 | $1.70 | $1.36 | $1.29 | — |
| الأسهم القائمة (م) | — | 122M | 128M | 132M | 138M | 142M | 143M | 149M | 154M | 158M | 162M | 168M | 171M | 175M | 180M | 185M | 187M | 181M | 182M | 182M | — |
المصدر: التقارير العامة للشركة (SEC). تحقق من SEC EDGAR قبل الاعتماد على أي رقم.
الميزانيات والتدفقات النقدية والبيانات الفصلية والنسب المالية الكاملة في العارض التفاعلي لـ HSIC. /companies/us/HSIC
المعلومات في هذا الموقع لأغراض تعليمية وإعلامية فقط ولا تشكل نصيحة استثمارية. لا تُنشر أسعار مستهدفة أو توصيات.
About TickerBase · Data methodology & sources · Privacy · Terms